Parametric Portfolio Associates’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Parametric Portfolio Associates’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$205K	Sell	49,741 -13,858	-22%	-$73.4K	﹤0.01%	3435
2021 Q4	$818K	Buy	63,599 +13,779	+28%	+$153K	﹤0.01%	2864
2021 Q3	$538K	Sell	49,820 -3,019	-6%	-$27.5K	﹤0.01%	3074
2021 Q2	$482K	Buy	52,839 +882	+2%	+$8.16K	﹤0.01%	3102
2021 Q1	$490K	Sell	51,957 -251	-0.5%	-$3.46K	﹤0.01%	3506
2020 Q4	$206K	Buy	52,208 +7,158	+16%	+$21.6K	﹤0.01%	3761
2020 Q3	$119K	Buy	+45,050	New	+$167K	﹤0.01%	3762

Other funds holding GRTS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return